Singapore’s largest non-cyclical consumer stocks by market cap focused on food production have averaged 5% defensive total returns since regional market highs on 9 June. The strongest performers of this group of SGX listed stocks over the period were Mewah International, Del Monte Pacific, ABR Holdings, QAF and Wilmar International.
In September, 24 SGX primary-listed stocks bought back shares for a total consideration of S$43 million. STI constituents Yangzijiang Shipbuilding, Keppel Corporation and ST Engineering led the buyback consideration in September. As many as 9 companies commenced new mandates, which included Ho Bee Land and Boustead Singapore.
The 30 Singapore stocks that saw the highest net institutional inflows in 3Q20 included stocks from Technology, Retail & Tourism related sectors. Venture Corporation, AEM Holdings, Mapletree Industrial Trust, UMS Holdings and Hi-P International were among the 30 stocks with a combined net institutional inflow of S$154 million in 3Q20.
The iEdge SG All Healthcare Index has generated a 30% total return in 3Q20, adding to its 37% total return in 1H20. Top Glove Reported 412% Net Profit Growth in FY20 & Provided Outlook Beyond 2020. Malaysia EPF Becomes Substantial Shareholder of Riverstone Holdings.
Singapore’s 5 most traded Consumer Cyclical stocks include Genting Singapore, Singapore Press Holdings, Jardine Cycle & Carriage, Sri Trang Agro-Industry and Accordia Golf Trust. Together the 5 stocks, have businesses that span multiple industries, as well as Singapore, ASEAN, Japan in addition to China. Sri Trang Agro-Industry has been the strongest performer of the 5 stocks.
Dasin Retail Trust topped Low Volatility factor exposure rankings of more than 100 actively traded Singapore stocks for the 12 months ending 30 June 2020. 8 Real Estate stocks also made up the 10 of the 40 Low Volatility factor exposure stocks with the highest net institutional inflow (proportionate to market capitalisation) in the 2020 year to 21 Sep.
Since the STI formed its 9 June high, through to 15 September, the most defensive of the five Industrial stocks was Yangzijiang Shipbuilding Holdings which declined 3.4% while the STI declined 9.5%.
In January, CapitaLand proposed a merger of CapitaLand Commercial Trust (CCT) and CapitaLand Mall Trust (CMT) in an S$8.3 billion cash-and-stock deal. In July, ESR-REIT and Sabana REIT announced a proposed merger, by way of a trust scheme of arrangement, which will see ESR-REIT acquiring all units of Sabana REIT from the unitholders of Sabana REIT
For 1H2020, the three banks averaged a net profit of S$1.80 billion, down an average 32.5% y-o-y. DBS reported the highest net profit figure of S$2.41 billion, and registered the smallest y-o-y decline in earnings, at 25.9%.
The FTSE Singapore Growth Index generated a 1.9% total return for the three years ending 31 Aug. Singapore’s 20 stocks with the highest growth factor exposure were led by AEM, represent multiple Sectors, and generated a median gain of 0.1%. 3 of the 20 stocks – Dasin Retail Trust, China Everbright Water and Sasseur REIT report all their revenue to China and 2 of the 20 stocks - Yangzijiang Shipbuilding and China Sunsine Chemicals report more than half their revenue to China.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.